Enzon Pharmaceuticals, Inc.
ENZN
$0.06
$0.005.26%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 42.57M | 43.26M | 44.29M | 44.97M | 46.86M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 239.00K | 411.00K | 444.00K | 555.00K | 293.00K |
| Total Current Assets | 42.81M | 43.67M | 44.74M | 45.52M | 47.15M |
|
|
|||||
| Total Current Assets | 42.81M | 43.67M | 44.74M | 45.52M | 47.15M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 26.00K | 42.00K | -- | 17.00K |
| Total Assets | 42.81M | 43.69M | 44.78M | 45.52M | 47.17M |
|
|
|||||
| Total Accounts Payable | 331.00K | 331.00K | 331.00K | 331.00K | 331.00K |
| Total Accrued Expenses | 42.00K | 67.00K | 62.00K | 220.00K | 72.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 358.00K | 142.00K | 410.00K | 3.00K | 1.28M |
| Total Other Current Liabilities | 358.00K | 142.00K | 410.00K | 3.00K | 1.28M |
| Total Current Liabilities | 731.00K | 540.00K | 803.00K | 554.00K | 1.68M |
|
|
|||||
| Total Current Liabilities | 731.00K | 540.00K | 803.00K | 554.00K | 1.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 731.00K | 540.00K | 803.00K | 554.00K | 1.68M |
|
|
|||||
| Common Stock & APIC | 70.78M | 71.31M | 71.84M | 72.37M | 72.90M |
| Retained Earnings | -73.30M | -72.23M | -71.41M | -70.42M | -69.89M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.53M | -923.00K | 432.00K | 1.95M | 3.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 44.61M | 44.08M | 43.55M | 43.01M | 42.48M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 44.61M | 44.08M | 43.55M | 43.01M | 42.48M |
|
|
|||||
| Total Common Equity | -2.53M | -923.00K | 432.00K | 1.95M | 3.01M |
| Total Preferred Equity | 44.61M | 44.08M | 43.55M | 43.01M | 42.48M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 42.08M | 43.15M | 43.98M | 44.97M | 45.49M |
|
|
|||||